| Phase 4 |
| NCT07344974 |
Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity |
Breast Cancer |
Not Yet Recruiting |
| NCT07599137 |
Abemaciclib Dose Escalation in Early High-Risk Breast Cancer Adjuvant Therapy |
HR+/HER2- Breast Cancer |
Not Yet Recruiting |
| Phase 2 |
| NCT07298148 |
Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8… |
NSCLC Stage IV |
Not Yet Recruiting |
| NCT07357532 |
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided… |
Small Cell Lung Carcinoma |
Not Yet Recruiting |
| NCT07383285 |
CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and… |
Rectal Neoplasms Malignant |
Not Yet Recruiting |
| NCT07381543 |
Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or… |
Localized Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT07394192 |
Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1… |
Rectal Cancer |
Not Yet Recruiting |
| NCT07417241 |
SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast… |
Breast Cancer |
Not Yet Recruiting |
| NCT07527806 |
Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer… |
Breast Cancer |
Not Yet Recruiting |
| NCT07567326 |
Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC |
Non Small Cell Lung Cancer |
Not Yet Recruiting |
| NCT07595523 |
Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric… |
Gastric Cancer |
Not Yet Recruiting |
| NCT07622706 |
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung… |
NSCLC |
Not Yet Recruiting |
| Phase 1 |
| NCT07413042 |
A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE… |
SCLC, Extensive Stage |
Recruiting |
| Early Phase 1 |
| NCT07590310 |
Clinical Application of CAIX-Targeted PET Imaging in Tumors |
Kidney Cancers |
Recruiting |
| Not specified |
| NCT06674252 |
A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified… |
Lung Cancers |
Recruiting |
| NCT05321316 |
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma |
Urothelial Carcinoma |
Recruiting |
| NCT05436093 |
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors |
Solid Tumor |
Recruiting |
| NCT07529002 |
Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors |
Solid Tumors |
Recruiting |
| NCT06909604 |
Al18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy |
Breast Cancer |
Recruiting |
| NCT06715020 |
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for… |
Breast Cancer |
Recruiting |
| NCT07353541 |
Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma |
Esophageal Squamous Cell Carcinoma (ESCC) |
Not Yet Recruiting |
| NCT07366047 |
Autologous Probiotics in Patients With Defunctioning Ileostomy Following LAR for Rectal… |
Rectal Cancer |
Not Yet Recruiting |
| NCT07442292 |
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor |
Lung Cancer (NSCLC) |
Not Yet Recruiting |
| NCT07470203 |
Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in… |
HER2-positive Breast Cancer |
Not Yet Recruiting |
| NCT07552207 |
Comparison of [68Ga]Ga-CTR-FAPI and 18F-FDG PET/MRI for Lymph Node Staging in Rectal… |
Rectal Cancer |
Not Yet Recruiting |